BPC-157 + TB-500 "The Powerful Duo" Serious musculoskeletal injuries muscle tears, tendon ruptures, significant strains where standard recovery timelines just arent cutting it
Journal of Clinical Pharmacology, 12(3), 245-258
Trial duration and follow up matter
A means to reduce systemic inflammation and minimize markers of tissue stress
That regulatory shift has consequences for research-grade supply as well: the quality variance across suppliers of research-grade incretin peptides is substantial, and sourcing decisions in 2026 should weight third-party lab verification and COA transparency more heavily than was common when compounding supply was abundant
Diarrhea (loose stools, post-antibiotics, travel) Not everyone on GLP-1 therapy is constipated